Deutsche Bank Ag\ Sorrento Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.74 - $1.83 $26,881 - $66,476	36,326 Added 22.04%	201,134 $179,000
Q3 2022 Nov 14, 2022	SELL	$1.51 - $2.88 $44,256 - $84,409	-29,309 Reduced 15.1%	164,808 $259,000
Q2 2022 Aug 11, 2022	BUY	$1.24 - $2.33 $11,789 - $22,153	9,508 Added 5.15%	194,117 $390,000
Q1 2022 May 13, 2022	SELL	$2.0 - $4.9 $36,560 - $89,572	-18,280 Reduced 9.01%	184,609 $429,000
Q4 2021 Feb 11, 2022	BUY	$4.65 - $7.23 $31,006 - $48,209	6,668 Added 3.4%	202,889 $944,000
Q3 2021 Nov 04, 2021	BUY	$7.41 - $10.99 $65,126 - $96,591	8,789 Added 4.69%	196,221 $1.5 Million
Q2 2021 Aug 11, 2021	BUY	$6.35 - $10.0 $8,737 - $13,760	1,376 Added 0.74%	187,432 $1.82 Million
Q1 2021 May 13, 2021	SELL	$7.03 - $16.51 $249,368 - $585,642	-35,472 Reduced 16.01%	186,056 $1.54 Million
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $532,575 - $1.1 Million	92,461 Added 71.64%	221,528 $1.51 Million
Q3 2020 Nov 12, 2020	BUY	$6.17 - $18.82 $196,310 - $598,795	31,817 Added 32.72%	129,067 $1.44 Million
Q2 2020 Aug 13, 2020	BUY	$1.73 - $6.76 $83,738 - $327,211	48,404 Added 99.1%	97,250 $610,000
Q1 2020 May 14, 2020	BUY	$1.57 - $4.76 $3,892 - $11,800	2,479 Added 5.35%	48,846 $90,000
Q4 2019 Feb 14, 2020	BUY	$1.45 - $4.17 $13,905 - $39,990	9,590 Added 26.08%	46,367 $155,000
Q3 2019 Nov 14, 2019	SELL	$2.05 - $2.69 $225,608 - $296,042	-110,053 Reduced 74.95%	36,777 $76,000
Q2 2019 Aug 14, 2019	SELL	$2.67 - $4.38 $261,443 - $428,885	-97,919 Reduced 40.01%	146,830 $390,000
Q1 2019 May 15, 2019	SELL	$1.86 - $5.94 $1.31 Million - $4.17 Million	-702,832 Reduced 74.17%	244,749 $1.16 Million
Q4 2018 Feb 14, 2019	BUY	$2.01 - $4.24 $406,132 - $856,717	202,056 Added 27.1%	947,581 $2.27 Million
Q3 2018 Dec 21, 2021	BUY	$4.22 - $7.5 $1.45 Million - $2.58 Million	344,242 Added 85.79%	745,525 $3.28 Million
Q3 2018 Nov 14, 2018	SELL	$4.22 - $7.5 $274,882 - $488,535	-65,138 Reduced 13.97%	401,283 $1.76 Million
Q2 2018 Apr 21, 2020	BUY	$4.75 - $8.0 $146,808 - $247,256	30,907 Added 7.1%	466,421 $3.36 Million
Q2 2018 Aug 14, 2018	SELL	$4.75 - $8.0 $2.39 Million - $4.02 Million	-502,392 Reduced 53.57%	435,514 $3.14 Million
Q1 2018 Oct 18, 2019	BUY	$4.5 - $9.95 $1.2 Million - $2.66 Million	267,361 Added 39.87%	937,906 $4.83 Million
Q1 2018 May 15, 2018	BUY	$4.5 - $9.95 $2.56 Million - $5.67 Million	569,924 Added 566.41%	670,545 $3.45 Million
Q4 2017 Feb 14, 2018	SELL	$1.75 - $3.8 $450,310 - $977,816	-257,320 Reduced 71.89%	100,621 $382,000
Q3 2017 Nov 14, 2017	BUY	$1.63 - $2.0 $583,443 - $715,882	357,941	357,941 $607,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account